ClinicalTrials.Veeva

Menu

Modulating Neuropathic Pain With Transcranial Direct Current Stimulation

S

Susan McDowell

Status

Terminated

Conditions

Complex Regional Pain Syndromes
Spinal Cord Injuries
Pain, Neuropathic
Phantom Limb Pain

Treatments

Device: transcranial direct current stimulation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will examine whether a form of non-invasive brain stimulation can help reduce pain in people with persistent neuropathic pain.

Full description

This study will look at the effects of a painless, non-invasive form of brain stimulation, called transcranial direct current stimulation, or tDCS. tDCS is thought to increase the brain's ability to change. Participants will be assigned to one of three groups by chance. Two groups will receive tDCS at a level expected to increase the brain's ability to change, while the other group will receive tDCS at a level not thought to affect the brain's ability to change.

Enrollment

18 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • At least 18 years of age
  • Have chronic (>12 months) neuropathic pain, including but not limited to complex regional pain syndrome, phantom limb pain, or pain of neurogenic origin following spinal cord injury

Exclusion criteria

  • History of seizures or epilepsy
  • Addition or change in the dosage of drugs now to interfere with pain within 1 month of enrollment
  • Untreated depression
  • History of head injury with loss of consciousness, severe alcohol or drug abuse, or psychiatric illness
  • Positive pregnancy test or being of childbearing age and not using appropriate contraception
  • Presence of ferromagnetic material in the cranium except in the mouth, including metal fragments from occupational exposure, and surgical clips in or near the brain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

18 participants in 3 patient groups

tDCS of DLPFC
Experimental group
Description:
Subjects will receive 20 minutes of active transcranial direct current stimulation at 2mA applied to the left dorsolateral prefrontal cortex (DLPFC). Subjects will undergo stimulation once a day for 10 consecutive weekdays.
Treatment:
Device: transcranial direct current stimulation
tDCS of M1
Experimental group
Description:
Subjects will receive 20 minutes of active transcranial direct current stimulation at 2mA applied to the left primary motor cortex (M1). Subjects will undergo stimulation once a day for 10 consecutive weekdays.
Treatment:
Device: transcranial direct current stimulation
Sham tDCS
Sham Comparator group
Description:
Subjects will receive 20 minutes of sham transcranial direct current stimulation. Subjects will undergo stimulation once a day for 10 consecutive weekdays.
Treatment:
Device: transcranial direct current stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems